LinkedIn·Friday, 17 July 2026·17 Jul 2026

🎉 Trince Welcomes James Lovgren to its Board of Directors! As Trince continues to expand adoption of its LumiPore platform across…

Trince

2,685 followers

🎉 Trince Welcomes James Lovgren to its Board of Directors! As Trince continues to expand adoption of its LumiPore platform across high-throughput drug discovery and advanced cell engineering applications, James' experience building and commercializing life science platforms will help guide the company's continued expansion. James has more than 25 years of experience and previously held executive leadership positions at MaxCyte, Berkeley Lights, and Thermo Fisher Scientific. His deep expertise in intracellular delivery, cell engineering, and the commercialization of enabling platforms makes him uniquely positioned to help guide Trince's next phase of growth. "I'm excited to join the Trince Board of Directors at such an important stage in the company's growth. Trince has developed a truly differentiated intracellular delivery platform with tremendous potential to accelerate scientific discovery and enable next-generation cell engineering. I look forward to working with the board and leadership team to help shape strategy, accelerate commercialization, and support the company's long-term success." — James Lovgren We are delighted to welcome James to the Board and look forward to benefiting from his strategic perspective and extensive industry experience as Trince continues to expand the impact of its LumiPore platform in drug discovery and advanced cell engineering.